CT and Angiography Agreement in Patients from the ISCHEMIA Trial

Computed tomographic (CT) angiography showed a high degree of agreement with conventional angiography to detect significant coronary artery disease and rule out left main disease.

tomografía y la angiografía ISCHEMIA

This imaging study was done on a group of patients before their randomization in the ISCHEMIA trial.

Data are soon to be published in JACC Cardiovascular Imaging and add plenty of evidence in favor of non-invasive diagnosis.

The rise of CT scans came about to solve the opposite problem. In this sense, its high negative predictive value prompted its use to rule out coronary artery disease in patients with unconvincing functional studies.

The power of CT vs. angiography in patients with high ischemic burden in functional assessments plus high probability of coronary artery disease had not been tested yet.

A “blinded” CT was performed before randomization to exclude the opposite ends of coronary artery disease—i.e., left main coronary artery and coronary arteries without lesion.

Randomization then defined the initial strategy, either conservative or invasive (the latter guided by angiography and optimum revascularization).


Read also: Post MI Betablockers for Good?


All lesions ≥50% were defined as anatomically significant.

Lesion in at least one vessel and lack of left main coronary artery lesions were detected by CT in about 1728 patients.

Conventional angiography confirmed the lack of left main coronary artery lesions in 97.1% of cases, and lesions in at least one vessel in 92.2% of cases. Only in 4.9% of patients did angiography not show significant lesions.


Read also: TAVR vs. the Least Invasive Surgically Implanted Valve.


Using a 70%—instead of 50%—stenosis diameter modified this excellent diagnostic precision.

Conclusion

CT showed an excellent agreement with angiography to identify patients with significant coronary artery lesions and rule out left main disease.

j-jcmg-2020-11-012free

Original Title: Coronary CT Angiography Followed by Invasive Angiography in Patients With Moderate or Severe Ischemia-Insights From the ISCHEMIA Trial.

Reference: G.B. John Mancini et al. J Am Coll Cardiol Img 2021, article in press. https://doi.org/10.1016/j.jcmg.2020.11.012.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...

Radial Patency in Coronary Procedures: Is Heparin Enough or Should We Aim for Distal Transradial Access?

Transradial access is the preferred route in most coronary procedures due to its proven reduction in mortality compared to transfemoral access. However, one of...

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

The assessment of coronary stenosis using coronary physiology has become a key tool in guiding revascularization. The two most widely used techniques are fractional...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...